Journal article

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Feldmann, M., Maini, R. N., Woody, J. N., Holgate, S. T., Winter, G., Rowland, M., Richards, D., & Hussell, T. (2020). Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed. Lancet, 395(10234), 1407–1409.

MLA Style

Feldmann, M., et al. “Trials of Anti-Tumour Necrosis Factor Therapy for COVID-19 Are Urgently Needed.” Lancet, vol. 395, no. 10234, Elsevier BV, 2020, pp. 1407–09.

Chicago Style

Feldmann, M, RN Maini, JN Woody, ST Holgate, G Winter, M Rowland, D Richards, and T Hussell. 2020. “Trials of Anti-Tumour Necrosis Factor Therapy for COVID-19 Are Urgently Needed.” Lancet 395 (10234): 1407–9.
Share
Print

Access Document

Publisher copy:: 10.1016/s0140-6736(20)30858-8

Authors

+ Feldmann, M More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Clinical Neurosciences
Sub department:: Clinical Neurosciences
Role:: Author

+ Maini, RN More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Clinical Neurosciences
Sub department:: Clinical Neurosciences
Role:: Author

+ Woody, JN More by this author

Role:: Author

+ Holgate, ST More by this author

Role:: Author

+ Winter, G More by this author

Role:: Author

More authors...

Publisher:: Elsevier BV
Journal:: Lancet More from this journal
Volume:: 395
Issue:: 10234
Pages:: 1407-1409
Publication date:: 2020-04-09
Acceptance date:: 2020-04-07
DOI:: 10.1016/s0140-6736(20)30858-8
EISSN:: 1474-547X
ISSN:: 0140-6736
Pmid:: 32278362

Language:: English
Keywords:: betacoronavirus

cytokines

tumor necrosis factor-alpha

coronavirus infections

pandemics

FFR

clinical trials as topic

antibodies

pneumonia, viral

inflammation
Pubs id:: 1101000
Local pid:: pubs:1101000
Deposit date:: 2020-06-19

Terms of use

Copyright holder:: Elsevier
Copyright date:: 2020
Rights statement:: © 2020 Elsevier Ltd. All rights reserved.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP